Searcharxiv⌕ Search

arXiv subjects

Mhaned Oubounyt

Publications and source records attributed to Mhaned Oubounyt.

3 recordsLinked to original sources

Quantum Optimisation for Protein-Protein Interaction Network Alignment

Protein-protein interaction (PPI) network alignment combines topological and sequence information to identify conserved modules across species, but global alignment remains challenging: heuristics sacrifice optimality, while exact methods lack scalability. We model the alignment as a weighted maximum common induced subgraph problem and reformulate it through the modular product graph to a minimum-weight vertex cover on the complement, with node weights carrying sequence similarity. To solve this problem, we develop a hybrid framework combining kernelisation, branch-and-bound, and seven Quantum Approximate Optimisation Algorithm (QAOA) formulations. These formulations differ in how the cover constraints are enforced, from penalty terms in the cost Hamiltonian to mixers confined to the feasible subspace. For single round QAOA, we derive closed-form expressions for the expected cost of four circulant mixer variants, enabling performance characterisation without circuit simulation. Applied to synthetic and real-world networks reduced to KEGG pathways, the QAOA formulations achieve high topological conservation on the aligned core while at least maintaining biological conservation comparable to leading classical aligners, at the cost of reduced node coverage. Across selected KEGG pathways, the aligned subnetworks retain disease-associated proteins, preserving biologically relevant information. Cheaper formulations leave more edges uncovered, while enforcing feasibility in the mixer raises circuit depth by one to two orders of magnitude. Together, these results highlight the potential of quantum optimisation for PPI network alignment and the resource trade-offs that will shape its scalability as quantum hardware matures.

quant-ph↗

Drugst.One -- A plug-and-play solution for online systems medicine and network-based drug repurposing

In recent decades, the development of new drugs has become increasingly expensive and inefficient, and the molecular mechanisms of most pharmaceuticals remain poorly understood. In response, computational systems and network medicine tools have emerged to identify potential drug repurposing candidates. However, these tools often require complex installation and lack intuitive visual network mining capabilities. To tackle these challenges, we introduce Drugst.One, a platform that assists specialized computational medicine tools in becoming user-friendly, web-based utilities for drug repurposing. With just three lines of code, Drugst.One turns any systems biology software into an interactive web tool for modeling and analyzing complex protein-drug-disease networks. Demonstrating its broad adaptability, Drugst.One has been successfully integrated with 21 computational systems medicine tools. Available at https://drugst.one, Drugst.One has significant potential for streamlining the drug discovery process, allowing researchers to focus on essential aspects of pharmaceutical treatment research.

q-bio.QM↗

Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing

Coronavirus Disease-2019 (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. It was first identified in Wuhan, China, and has since spread causing a global pandemic. Various studies have been performed to understand the molecular mechanisms of viral infection for predicting drug repurposing candidates. However, such information is spread across many publications and it is very time-consuming to access, integrate, explore, and exploit. We developed CoVex, the first interactive online platform for SARS-CoV-2 and SARS-CoV-1 host interactome exploration and drug (target) identification. CoVex integrates 1) experimentally validated virus-human protein interactions, 2) human protein-protein interactions and 3) drug-target interactions. The web interface allows user-friendly visual exploration of the virus-host interactome and implements systems medicine algorithms for network-based prediction of drugs. Thus, CoVex is an important resource, not only to understand the molecular mechanisms involved in SARS-CoV-2 and SARS-CoV-1 pathogenicity, but also in clinical research for the identification and prioritization of candidate therapeutics. We apply CoVex to investigate recent hypotheses on a systems biology level and to systematically explore the molecular mechanisms driving the virus life cycle. Furthermore, we extract and discuss drug repurposing candidates involved in these mechanisms. CoVex renders COVID-19 drug research systems-medicine-ready by giving the scientific community direct access to network medicine algorithms integrating virus-host-drug interactions. It is available at https://exbio.wzw.tum.de/covex/.

q-bio.MN↗